MicroRNAs as B-cell lymphoma biomarkers
Lorea Manterola,1 Marta Fernandez-Mercado,1 Erika Larrea,1 Ibai Goicoechea,1 María Arestin,1 María Armesto,1 Luiza Hernandez,1 Charles H Lawrie1,2,3 1Oncology Area, Biodonostia Research Institute, San Sebastián, Spain; 2Nuffield Department of Clinical Laboratory Sci...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16162ae744164af9afa9f88937cee74f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:16162ae744164af9afa9f88937cee74f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:16162ae744164af9afa9f88937cee74f2021-12-02T03:23:49ZMicroRNAs as B-cell lymphoma biomarkers1179-9889https://doaj.org/article/16162ae744164af9afa9f88937cee74f2015-02-01T00:00:00Zhttp://www.dovepress.com/micrornas-as-b-cell-lymphoma-biomarkers-peer-reviewed-article-BLCTThttps://doaj.org/toc/1179-9889 Lorea Manterola,1 Marta Fernandez-Mercado,1 Erika Larrea,1 Ibai Goicoechea,1 María Arestin,1 María Armesto,1 Luiza Hernandez,1 Charles H Lawrie1,2,3 1Oncology Area, Biodonostia Research Institute, San Sebastián, Spain; 2Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK; 3Ikerbasque, Basque Foundation for Science, Bilbao, Spain Abstract: B-cell lymphomas represent a group of more than 35 recognized mature B-cell neoplasms differentiated largely on the basis of immunohistochemical staining patterns that are often challenging to accurately diagnose. Despite having been only formally recognized just over 10 years ago, microRNAs (miRNAs) have become one of the trendiest topics in biology. Dysregulation of miRNAs is a ubiquitous feature of cancer in general, including B-cell lymphomas. Many of the miRNAs aberrantly expressed in B-cell lymphomas also play a crucial regulatory role in normal hematopoietic function. MiRNAs show great potential as novel biomarkers of cancer, as they can differentiate cancers according to diagnosis and developmental stage, even discriminating between cancers that are poorly separated histologically. Furthermore, they can be robustly measured from routinely prepared formalin-fixed paraffin-embedded biopsy material and biological fluids such as blood. Here, we consider the identity, function, and biomarker potential of miRNAs in B-cell lymphomas and, most importantly, the hurdles that remain to be overcome if they are really to become part of future clinical practice. Keywords: microRNA, lymphoma, biomarker, B-cell Manterola LFernandez-Mercado MLarrea EGoicoechea IArestin MArmesto MHernandez LLawrie CHDove Medical PressarticleDiseases of the blood and blood-forming organsRC633-647.5ENBlood and Lymphatic Cancer: Targets and Therapy, Vol 2015, Iss default, Pp 25-34 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the blood and blood-forming organs RC633-647.5 |
spellingShingle |
Diseases of the blood and blood-forming organs RC633-647.5 Manterola L Fernandez-Mercado M Larrea E Goicoechea I Arestin M Armesto M Hernandez L Lawrie CH MicroRNAs as B-cell lymphoma biomarkers |
description |
Lorea Manterola,1 Marta Fernandez-Mercado,1 Erika Larrea,1 Ibai Goicoechea,1 María Arestin,1 María Armesto,1 Luiza Hernandez,1 Charles H Lawrie1,2,3 1Oncology Area, Biodonostia Research Institute, San Sebastián, Spain; 2Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK; 3Ikerbasque, Basque Foundation for Science, Bilbao, Spain Abstract: B-cell lymphomas represent a group of more than 35 recognized mature B-cell neoplasms differentiated largely on the basis of immunohistochemical staining patterns that are often challenging to accurately diagnose. Despite having been only formally recognized just over 10 years ago, microRNAs (miRNAs) have become one of the trendiest topics in biology. Dysregulation of miRNAs is a ubiquitous feature of cancer in general, including B-cell lymphomas. Many of the miRNAs aberrantly expressed in B-cell lymphomas also play a crucial regulatory role in normal hematopoietic function. MiRNAs show great potential as novel biomarkers of cancer, as they can differentiate cancers according to diagnosis and developmental stage, even discriminating between cancers that are poorly separated histologically. Furthermore, they can be robustly measured from routinely prepared formalin-fixed paraffin-embedded biopsy material and biological fluids such as blood. Here, we consider the identity, function, and biomarker potential of miRNAs in B-cell lymphomas and, most importantly, the hurdles that remain to be overcome if they are really to become part of future clinical practice. Keywords: microRNA, lymphoma, biomarker, B-cell |
format |
article |
author |
Manterola L Fernandez-Mercado M Larrea E Goicoechea I Arestin M Armesto M Hernandez L Lawrie CH |
author_facet |
Manterola L Fernandez-Mercado M Larrea E Goicoechea I Arestin M Armesto M Hernandez L Lawrie CH |
author_sort |
Manterola L |
title |
MicroRNAs as B-cell lymphoma biomarkers |
title_short |
MicroRNAs as B-cell lymphoma biomarkers |
title_full |
MicroRNAs as B-cell lymphoma biomarkers |
title_fullStr |
MicroRNAs as B-cell lymphoma biomarkers |
title_full_unstemmed |
MicroRNAs as B-cell lymphoma biomarkers |
title_sort |
micrornas as b-cell lymphoma biomarkers |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/16162ae744164af9afa9f88937cee74f |
work_keys_str_mv |
AT manterolal micrornasasbcelllymphomabiomarkers AT fernandezmercadom micrornasasbcelllymphomabiomarkers AT larreae micrornasasbcelllymphomabiomarkers AT goicoecheai micrornasasbcelllymphomabiomarkers AT arestinm micrornasasbcelllymphomabiomarkers AT armestom micrornasasbcelllymphomabiomarkers AT hernandezl micrornasasbcelllymphomabiomarkers AT lawriech micrornasasbcelllymphomabiomarkers |
_version_ |
1718401778401148928 |